January 21, 2019 by Chain Drug Review
Alex Gourlay, WBA
January 21, 2019, News
SAN FRANCISCO — During a fireside chat at the annual J.P. Morgan Healthcare Conference here earlier this month, Walgreens Boots Alliance (WBA) co-chief operating officer Alex Gourlay spoke to the number of partnerships the company has brought to the marketplace as well as the future of health care. WBA has always viewed vertical integration positively,
January 7, 2019 by Chain Drug Review
Annie Murphy, Colin Nelson, Vineet Mehra, WBA
January 7, 2019, News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) recently announced three global leadership appointments. Vineet Mehra will be joining WBA as global chief marketing officer. He will be based at corporate headquarters here and will report to WBA co-chief operating officers Ornella Barra and Alex Gourlay. As global CMO, Mehra will be responsible for the visioning,
December 21, 2018 by Chain Drug Review
Annie Murphy, Colin Nelson, Vineet Mehra, WBA
Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. has announced three global leadership appointments. Vineet Mehra will be joining WBA as global chief marketing officer. He will be based at corporate headquarters in Deerfield and report to WBA co-chief operating officers Ornella Barra and Alex Gourlay. As global CMO, Mehra will be responsible for the visioning, leadership, strategic
July 9, 2018 by Chain Drug Review
WBA
Issue 07-09-2018
NEW YORK — Walgreens Boots Alliance (WBA) late last month took its place alongside Boeing, Merck & Co., Walmart and other large, publicly traded U.S. companies that comprise the Dow Jones industrial average, the stock index that tracks daily trading in 30 of the world’s best-known blue chips. General Electric Co. was dropped to make
June 4, 2018 by Chain Drug Review
Stefano Pessina, Walgreens, WBA
Issue 06-04-2018
NEW YORK — Walgreens Boots Alliance executive vice chairman and chief executive officer Stefano Pessina urged analysts not to think they can see the future of Walgreens simply by visiting the company’s new pilot stores in Gainesville, Fla. “Let’s be clear,” Pessina said during a sell-side analyst event in New York last month. “Gainesville today
April 17, 2018 by Chain Drug Review
Rite Aid, WBA
Issue 04-09-2018, News
CAMP HILL, Pa. — Rite Aid Corp. has completed the transfer of 1,932 stores purchased by Walgreens Boots Alliance Inc. The transfer of three distribution centers and related inventory is expected to begin after September 1. The majority of the closing conditions of WBA’s $4.375 billion acquisition of the stores and warehouses have been satisfied,
March 6, 2018 by Chain Drug Review
Albertsons Cos., Albertsons-Rite Aid, Bob Miller, John Standley, Rite Aid, Rite Aid asset sale, Walgreens Boots Alliance, WBA
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — Rite Aid Corp. is winding down its asset sale to Walgreens Boots Alliance (WBA) with the ownership transfer of 537 more stores. Rite Aid said Tuesday that as of March 2, it has transferred 1,651 stores and related assets to WBA for cash proceeds of $3.6 billion. The process has progressed
February 13, 2018 by Chain Drug Review
Alliance Boots, AmerisourceBergen, Stefano Pessina, Steven Collis, Walgreens Boots Alliance, Walgreens Boots Alliance Development, WBA, WBAD
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) is in negotiations to acquire drug distributor AmerisourceBergen Corp., according to published reports. Representatives of WBA executive vice chairman and chief executive officer Stefano Pessina made “a high-level outreach” to representatives of AmerisourceBergen chairman and CEO Steven Collis several weeks ago, The Wall Street Journal reported, citing people familiar
January 2, 2018 by Jeffrey Woldt and Chain Drug Review
Alex Gourlay, Chain Drug Review, Ornella Barra, Retailer of the Year, Retailer of the Year Award, Rite Aid, Walgreens, Walgreens Boots Alliance, WBA
2018, Featured Articles, Issue 01-01-2018, Issues, Leading Headlines, News, Retail News
DEERFIELD, Ill. — To the casual observer, the dominant story line at Walgreens might appear to be the phased acquisition of 1,932 drug stores and related assets from Rite Aid Corp., and plans for their subsequent assimilation. But, important as the deal is, it shouldn’t be allowed to obscure other compelling developments at Walgreens Boots
October 25, 2017 by Chain Drug Review
George Fairweather, Rite Aid, Rite Aid asset sale, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) plans to close 600 stores starting next year as it rationalizes its U.S. drug store base following the $4.375 billion purchase of 1,932 Rite Aid stores. In reporting its fiscal 2017 fourth-quarter and annual results on Wednesday, WBA said it expects to finalize the Rite Aid store acquisition
July 25, 2017 by Chain Drug Review
Fareva, Walgreens Boots Alliance Inc., WBA
Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) announced on Tuesday a binding offer from Fareva for a 10-year global agreement for the manufacture and supply of own brand beauty products and private label items, including products for sale in the United States. The proposed agreement will create a partnership to provide WBA with a
January 5, 2017 by Chain Drug Review
Fred's, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) edged past Wall Street’s adjusted earnings per share forecast in its fiscal 2017 first quarter despite declined sales and net income. WBA also reported Thursday that it’s still working to finalize its $17 billion deal to acquire Rite Aid Corp. and continues to expect to complete the transaction
December 20, 2016 by Chain Drug Review
Fred’s Inc., Rite Aid Corp., Walgreens Boots Alliance Inc., WBA
Featured Articles, Leading Headlines, News, Retail News
NEW YORK — Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. have entered into an agreement to sell 865 Rite Aid stores and certain assets related to store operations to Fred’s Inc. for $950 million. The all-cash transaction, announced Tuesday, is subject to Federal Trade Commission approval, as well as the completion of the
November 11, 2016 by CDR Blog and Chain Drug Review
Adam Fein, CVS Caremark, CVS Health, CVS Pharmacy, Drug Channels, Drug Channels Institute, Maintenance Choice, OptumRx, Pembroke Consulting, pharmacy industry, Prime Therapeutics, Tricare, Walgreens Boots Alliance, WBA
CDR Blog
CVS Health’s scaled-back 2017 guidance, given in its third-quarter report this week, spotlights an intensifying competitive battle with rival Walgreens Boots Alliance. CVS reported that for fiscal 2017 it expects to lose over 40 million retail prescriptions due to marketplace changes, notably narrower retail pharmacy networks excluding CVS Pharmacy drug stores. The announcement sent CVS